Publications
By Year
Now showing items 341-360 of 5027 records
Cord blood lipid correlation network profiles are associated with subsequent attention-deficit/hyperactivity disorder and autism spectrum disorder symptoms at 2 years: a prospective birth cohort study.
Kristina Vacy; Sarah Thomson; Archer Moore; Alex Eisner; Sam Tanner; Cindy Pham; Richard Saffery; Toby Mansell; David Burgner; Fiona Collier; Peter Vuillermin; Martin O'Hely; Wah Chin Boon; Peter Meikle; Satvika Burugupalli; Anne-Louise Ponsonby
EBIOMEDICINE - 01 Feb 2024
Attention-deficit/hyperactivity disorder (ADHD) and autism spectrum disorder (ASD) are neurodevelopmental conditions with early life origins. Alterations in blood lipids have been linked to ADHD and ASD; however, prospective early life data are limited. This study examined (i) associations between the cord blood lipidome and ADHD/ASD symptoms at 2 years of age, (ii) associations between prenata...
Aortic Cellular Heterogeneity in Health and Disease: Novel Insights Into Aortic Diseases From Single-Cell RNA Transcriptomic Data Sets.
Tayla A Gibson Hughes; Malathi S I Dona; Christopher G Sobey; Alexander R Pinto; Grant R Drummond; Antony Vinh; Maria Jelinic
HYPERTENSION (DALLAS, TEX. : 1979) - 01 Apr 2024
Aortic diseases such as atherosclerosis, aortic aneurysms, and aortic stiffening are significant complications that can have significant impact on end-stage cardiovascular disease. With limited pharmacological therapeutic strategies that target the structural changes in the aorta, surgical intervention remains the only option for some patients with these diseases. Although there have been signi...
Improved Glycemic Outcomes With Diabetes Technology Use Independent of Socioeconomic Status in Youth With Type 1 Diabetes.
Kate E Lomax; Craig E Taplin; Mary B Abraham; Grant J Smith; Aveni Haynes; Ella Zomer; Katrina L Ellis; Helen Clapin; Sophia Zoungas; Alicia J Jenkins; Jennifer Harrington; Martin I de Bock; Timothy W Jones; Elizabeth A Davis;
DIABETES CARE - 01 Apr 2024
Technology use in type 1 diabetes (T1D) is impacted by socioeconomic status (SES). This analysis explored relationships between SES, glycemic outcomes, and technology use. A cross-sectional analysis of HbA1c data from 2,822 Australian youth with T1D was undertaken. Residential postcodes were used to assign SES based on the Index of Relative Socio-Economic Disadvantage (IRSD). Linear regression ...
Correction to: The Effect of Sedentary Behaviour on Cardiorespiratory Fitness: A Systematic Review and Meta-Analysis.
Stephanie A Prince; Paddy C Dempsey; Jennifer L Reed; Lukas Rubin; Travis J Saunders; Josephine Ta; Grant R Tomkinson; Katherine Merucci; Justin J Lang
SPORTS MEDICINE (AUCKLAND, N.Z.) - 01 Apr 2024
Biased effects of pre-diagnostic physical activity on breast cancer survival: Systematic review and meta-analysis.
Ziyu Wang; Frances Em Albers; Sabrina E Wang; Dallas R English; Brigid M Lynch
CANCER EPIDEMIOLOGY - 01 Apr 2024
Pre-diagnostic physical activity is reported to improve survival for women with breast cancer. However, studies of pre-diagnostic exposures and cancer survival are susceptible to bias, made clear when applying a target trial framework. We investigated the impact of selection bias, immortal time bias, confounding and bias due to inappropriate adjustment for post-exposure variables in a systemati...
Sedentary behavior and lifespan brain health.
Liye Zou; Fabian Herold; Boris Cheval; Michael J Wheeler; Dominika M Pindus; Kirk I Erickson; David A Raichlen; Gene E Alexander; Notger G Müller; David W Dunstan; Arthur F Kramer; Charles H Hillman; Mats Hallgren; Ulf Ekelund; Silvio Maltagliati; Neville Owen
TRENDS IN COGNITIVE SCIENCES - 01 Apr 2024
Higher levels of physical activity are known to benefit aspects of brain health across the lifespan. However, the role of sedentary behavior (SB) is less well understood. In this review we summarize and discuss evidence on the role of SB on brain health (including cognitive performance, structural or functional brain measures, and dementia risk) for different age groups, critically compare asse...
An overview of therapeutic options of obesity management in India: the Integrated Diabetes and Endocrinology Academy (IDEA) 2023 Congress update.
Subir Ray; Nitin Kapoor; Neeta Deshpande; Sanjay Chatterjee; Janardanan Kumar; Om Tantia; Ghanshyam Goyal; Jagat Jyoti Mukherjee; Awadhesh Kumar Singh
EXPERT REVIEW OF CLINICAL PHARMACOLOGY - 01 Apr 2024
With newer anti-obesity medications (AOMs) being introduced at a rapid pace, it is prudent to make a concise and updated clinical practice document that may help busy clinicians in daily clinical practice. A group of metabolic physicians, diabetologists, endocrinologists, and bariatric surgeons assembled during the Integrated Diabetes and Endocrine Academy 2023 Congress (IDEACON, July 2023, Kol...
Integration of polygenic and gut metagenomic risk prediction for common diseases.
Yang Liu; Scott C Ritchie; Shu Mei Teo; Matti O Ruuskanen; Oleg Kambur; Qiyun Zhu; Jon Sanders; Yoshiki Vázquez-Baeza; Karin Verspoor; Pekka Jousilahti; Leo Lahti; Teemu Niiranen; Veikko Salomaa; Aki S Havulinna; Rob Knight; Guillaume Méric; Michael Inouye
NATURE AGING - 01 Apr 2024
Multiomics has shown promise in noninvasive risk profiling and early detection of various common diseases. In the present study, in a prospective population-based cohort with ~18 years of e-health record follow-up, we investigated the incremental and combined value of genomic and gut metagenomic risk assessment compared with conventional risk factors for predicting incident coronary artery dise...
Sympathetic Pathophysiology in Hypertension Origins: The Path to Renal Denervation.
Murray D Esler; John W Osborn; Markus P Schlaich
HYPERTENSION (DALLAS, TEX. : 1979) - 01 Apr 2024
The importance of the sympathetic nervous system in essential hypertension has been recognized in 2 eras. The first was in early decades of the 20<sup>th</sup> century, through to the 1960s. Here, the sympathetic nervous system was identified as a target for the treatment of hypertension, and an extensive range of antiadrenergic therapies were developed. Then, after a period of lapsed interest,...
Making Waves in HFpEF: Unmasking Severe Left Atrial Myopathy During Exercise.
Misha Dagan; David M Kaye
CIRCULATION. HEART FAILURE - 01 Apr 2024
A lipid atlas of human and mouse immune cells provides insights into ferroptosis susceptibility.
Pooranee K Morgan; Gerard Pernes; Kevin Huynh; Corey Giles; Sudip Paul; Adam Alexander T Smith; Natalie A Mellett; Amy Liang; Tilly van Buuren-Milne; Camilla Bertuzzo Veiga; Thomas J C Collins; Yangsong Xu; Man K S Lee; T Michael De Silva; Peter J Meikle; Graeme I Lancaster; Andrew J Murphy
NATURE CELL BIOLOGY - 01 Apr 2024
The cellular lipidome comprises thousands of unique lipid species. Here, using mass spectrometry-based targeted lipidomics, we characterize the lipid landscape of human and mouse immune cells ( www.cellularlipidatlas.com ). Using this resource, we show that immune cells have unique lipidomic signatures and that processes such as activation, maturation and development impact immune cell lipid co...
Comparison of <i>tet</i>(X4)-containing contigs assembled from metagenomic sequencing data with plasmid sequences of isolates from a cohort of healthy subjects.
Yichen Ding; Shuan Er; Abel Tan; Jean-Sebastien Gounot; Woei-Yuh Saw; Linda Wei Lin Tan; Yik Ying Teo; Niranjan Nagarajan; Henning Seedorf
MICROBIOLOGY SPECTRUM - 02 Apr 2024
Recently discovered <i>tet</i>(X) gene variants have provided new insights into microbial antibiotic resistance mechanisms and their potential consequences for public health. This study focused on detection, analysis, and characterization of Tet(X4)-positive Enterobacterales from the gut microbiota of a healthy cohort of individuals in Singapore using cultivation-dependent and cultivation-indep...
Blood Pressure Lowering in Patients With Central Hypertension: A randomized Clinical Trial.
James E Sharman; Petr Otahal; Michael Stowasser; Tony Stanton; Christopher M Reid; Mark Nolan; Philip Roberts-Thomson; Kazuaki Negishi; Robert Greenough; Simon Stewart; Thomas H Marwick; Walter P Abhayaratna
HYPERTENSION (DALLAS, TEX. : 1979) - 02 Apr 2024
Cuff blood pressure (BP) is recommended for guiding hypertension management. However, central BP has been proposed as a superior clinical measurement. This study aimed to determine whether controlling hypertension as measured by central BP was beneficial in reducing left ventricular mass index beyond control of standard cuff hypertension. This multicenter, open-label, blinded-end point trial wa...
Relative associations of behavioral and physiological risks for cardiometabolic disease with cognition in bipolar disorder during mid and later-life: findings from the UK biobank.
Elysha Ringin; David W Dunstan; Denny Meyer; Roger S McIntyre; Neville Owen; Michael Berk; Mats Hallgren; Susan L Rossell; Tamsyn E Van Rheenen
PSYCHOLOGICAL MEDICINE - 02 Apr 2024
Cardiometabolic disease risk factors are disproportionately prevalent in bipolar disorder (BD) and are associated with cognitive impairment. It is, however, unknown which health risk factors for cardiometabolic disease are relevant to cognition in BD. This study aimed to identify the cardiometabolic disease risk factors that are the most important correlates of cognitive impairment in BD; and t...
Kidney trajectory charts improve GP management of patients with reduced kidney function: a randomised controlled vignette study.
Michelle Guppy; Paul Glasziou; Mark Jones; Elaine Beller; Jonathan E Shaw; Elizabeth Barr; Jenny Doust
BJGP OPEN - 02 Apr 2024
The stages of chronic kidney disease (CKD) and estimated glomerular filtration rate (eGFR) reference ranges are currently determined without considering age. To determine whether a chart that graphs age with eGFR helps GPs make better decisions about managing patients with declining eGFR. A randomised controlled vignette study among Australian GPs using a percentile chart plotting the trajector...
Editorial: The role of GPCRs in obesity.
Chunye Zhang; Yi Wang; Takefumi Kimura; Ahmad H Al-Mrabeh
FRONTIERS IN ENDOCRINOLOGY - 01 Jan 2024
Opportunities and Limitations of Renal Denervation: Where Do We Stand?
Beatriz Castillo Rodriguez; Eric A Secemsky; Rajesh V Swaminathan; Dmitriy N Feldman; Markus Schlaich; Yuri Battaglia; Edward Filippone; Chayakrit Krittanawong
THE AMERICAN JOURNAL OF MEDICINE - 06 Apr 2024
Hypertension is a primary contributor to cardiovascular disease, and the leading risk factor for loss of quality adjusted life years. Up to 50% of the cases of hypertension in the US remain uncontrolled. Additionally, 8-18% of the hypertensive population have resistant hypertension, uncontrolled pressure despite three different anti-hypertensive agents. Recently, catheter-based, percutaneous re...
Prognostic and functional importance of both overt and subclinical left ventricular systolic dysfunction in systemic sclerosis.
Jessica L Fairley; Dylan Hansen; Susanna Proudman; Joanne Sahhar; Gene-Siew Ngian; Jenny Walker; Lauren V Host; André La Gerche; David Prior; Andrew Burns; Kathleen Morrisroe; Wendy Stevens; Mandana Nikpour; Laura Ross
06 Apr 2024
To quantify the frequency and clinical implications of systemic sclerosis (SSc)-associated left ventricular function (LV) impairment. Australian Scleroderma Cohort Study participants meeting ACR/EULAR criteria for SSc with ≥1 echocardiographic LVEF measurement were included. Overt LV dysfunction was indicated by reduced LV ejection fraction (LVEF) and subclinical LV dysfunction was measured usi...
Recommendations for the Use of Dietary Fiber to Improve Blood Pressure Control.
Hamdi A Jama; Matthew Snelson; Aletta E Schutte; Jane Muir; Francine Z Marques
HYPERTENSION (DALLAS, TEX. : 1979) - 08 Apr 2024
According to several international, regional, and national guidelines on hypertension, lifestyle interventions are the first-line treatment to lower blood pressure (BP). Although diet is one of the major lifestyle modifications described in hypertension guidelines, dietary fiber is not specified. Suboptimal intake of foods high in fiber, such as in Westernized diets, is a major contributing fac...
Non-High-Density Lipoprotein Cholesterol Levels From Childhood to Adulthood and Cardiovascular Disease Events.
Feitong Wu; David R Jacobs; Stephen R Daniels; Mika Kähönen; Jessica G Woo; Alan R Sinaiko; Jorma S A Viikari; Lydia A Bazzano; Julia Steinberger; Elaine M Urbina; Alison J Venn; Olli T Raitakari; Terence Dwyer; Markus Juonala; Costan G Magnussen
JAMA - 12 Apr 2024
Elevated non-high-density lipoprotein cholesterol (non-HDL-C; a recommended measure of lipid-related cardiovascular risk) is common in children and increases risk of adult cardiovascular disease (CVD). Whether resolution of elevated childhood non-HDL-C levels by adulthood is associated with reduced risk of clinical CVD events is unknown. To examine the associations of non-HDL-C status between c...
Show more...